1,131 Shares in Relx Plc (NYSE:RELX) Bought by D Orazio & Associates Inc.

D Orazio & Associates Inc. acquired a new stake in Relx Plc (NYSE:RELX) in the 3rd quarter, HoldingsChannel.com reports. The fund acquired 1,131 shares of the technology company’s stock, valued at approximately $33,000.

Several other institutional investors have also recently made changes to their positions in RELX. Vigilant Capital Management LLC acquired a new position in Relx during the third quarter valued at $26,000. Advisory Services Network LLC acquired a new position in Relx in the 2nd quarter worth about $33,000. Toronto Dominion Bank increased its holdings in shares of Relx by 38.0% during the 2nd quarter. Toronto Dominion Bank now owns 3,980 shares of the technology company’s stock valued at $106,000 after acquiring an additional 1,095 shares during the last quarter. FMR LLC increased its holdings in shares of Relx by 10.9% during the 1st quarter. FMR LLC now owns 5,058 shares of the technology company’s stock valued at $108,000 after acquiring an additional 498 shares during the last quarter. Finally, Concourse Financial Group Securities Inc. increased its holdings in shares of Relx by 11.7% during the 3rd quarter. Concourse Financial Group Securities Inc. now owns 4,196 shares of the technology company’s stock valued at $121,000 after acquiring an additional 440 shares during the last quarter. Institutional investors and hedge funds own 5.70% of the company’s stock.

NYSE RELX opened at $30.20 on Friday. The business has a fifty day moving average price of $31.40 and a two-hundred day moving average price of $30.26. The company has a debt-to-equity ratio of 2.50, a quick ratio of 0.46 and a current ratio of 0.53. Relx Plc has a fifty-two week low of $23.37 and a fifty-two week high of $32.71.

Several research analysts have recently issued reports on the company. Citigroup lowered Relx from a “buy” rating to a “neutral” rating in a research report on Thursday, January 6th. UBS Group upgraded Relx from a “neutral” rating to a “buy” rating in a report on Friday. Credit Suisse Group reiterated an “outperform” rating on shares of Relx in a report on Thursday, October 7th. Zacks Investment Research lowered Relx from a “buy” rating to a “hold” rating in a report on Wednesday, December 15th. Finally, Barclays restated an “overweight” rating on shares of Relx in a report on Friday, October 22nd. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Relx currently has a consensus rating of “Buy” and an average target price of $33.00.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Recommended Story: How to Invest in Stocks with Increasing Dividends

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX).

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.